By Daniel Kantor, MD, FAAN, FANA
LETTER FROM THE EDITOR
By Waimei Amy Tai, MD
By Michelle L. Dougherty, MD
By David B. Mandell, JD, MBA, and Jason M. O’Dell, MS, CWM
Current Efforts and Considerations
By Paul Singh, MD, MPH
Results of the DAWN trial expand the beneficial role of stent retrieval therapy for acute ischemic stroke beyond the conventional time window.
By Ashutosh P. Jadhav, MD, PhD
Data from three randomized clinical trials offer promising results for the use of patent foramen ovale closure in the treatment of cryptogenic stroke.
By Dominik M. Wiktor, MD, and John D. Carroll, MD
A look back at the long road to FDA approval and the implications on patient care options going forward.
By Marie-France Poulin, MD, and Clifford J. Kavinsky, MD, PhD
How neurology plays a central role in determining cause and treatment of stroke.
By Scott E. Kasner, MD
What neurologists need to know to ensure optimal patient selection.
By David Z. Rose, MD
A guide to simplify stroke patient dispositions.
By Vivek Sindhi, MD, MBA, John Norbury, MD, Clinton Faulk, MD, Dimtri Avgeropoulos, Ian Lee, MD, and Steven Mandel, MD
The Next Frontier in Stroke Treatment